Wu et al. (2021) found that there is elevated expression of KIFC1 in GBM and its inhibition suppressed proliferation and resistance to temozolomide. Dai et al. (2017) also showed that KIFC1 is up-regulated in grade III gliomas, like in our study. This evidence concerns the gene KIFC1 and central nervous system cancer.